[go: up one dir, main page]

ATE442441T1 - Virale expressionsvektoren für pflanzen - Google Patents

Virale expressionsvektoren für pflanzen

Info

Publication number
ATE442441T1
ATE442441T1 AT00930426T AT00930426T ATE442441T1 AT E442441 T1 ATE442441 T1 AT E442441T1 AT 00930426 T AT00930426 T AT 00930426T AT 00930426 T AT00930426 T AT 00930426T AT E442441 T1 ATE442441 T1 AT E442441T1
Authority
AT
Austria
Prior art keywords
altered
plants
movement protein
expression vectors
viral expression
Prior art date
Application number
AT00930426T
Other languages
English (en)
Inventor
Wayne Fitzmaurice
Gregory Pogue
John Lindbo
Original Assignee
Kentucky Bioproc Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kentucky Bioproc Llc filed Critical Kentucky Bioproc Llc
Application granted granted Critical
Publication of ATE442441T1 publication Critical patent/ATE442441T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00041—Use of virus, viral particle or viral elements as a vector
    • C12N2770/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT00930426T 1999-05-04 2000-05-04 Virale expressionsvektoren für pflanzen ATE442441T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13269799P 1999-05-04 1999-05-04
PCT/US2000/012380 WO2000066743A2 (en) 1999-05-04 2000-05-04 Viral expression vectors

Publications (1)

Publication Number Publication Date
ATE442441T1 true ATE442441T1 (de) 2009-09-15

Family

ID=22455189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00930426T ATE442441T1 (de) 1999-05-04 2000-05-04 Virale expressionsvektoren für pflanzen

Country Status (13)

Country Link
US (2) US6656726B1 (de)
EP (1) EP1181372B1 (de)
JP (1) JP4750285B2 (de)
KR (1) KR20020000802A (de)
AT (1) ATE442441T1 (de)
AU (1) AU781020B2 (de)
BR (1) BR0010222A (de)
CA (1) CA2373026C (de)
DE (1) DE60042922D1 (de)
ES (1) ES2332982T3 (de)
IL (1) IL146191A0 (de)
WO (1) WO2000066743A2 (de)
ZA (1) ZA200108528B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000066743A2 (en) 1999-05-04 2000-11-09 Large Scale Biology Corporation Viral expression vectors
US20080160040A1 (en) * 2004-04-15 2008-07-03 Ghim Shin-Je Plant-produced compositions for treating papillomavirus infection and related methods
MX2007008132A (es) * 2004-12-30 2007-07-20 Schering Plough Ltd Vacuna para aumentar el crecimiento basada en epitopes neutralizantes.
CA2621466A1 (en) * 2005-09-08 2007-04-05 Kentucky Bioprocessing, Llc Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
WO2008094512A2 (en) * 2007-01-29 2008-08-07 The Ohio Sate University Research Foundation System for expression of genes in plants from a virus-based expression vector
JP6302415B2 (ja) * 2012-12-21 2018-03-28 株式会社ＵｎｉＢｉｏ ヒト上皮細胞増殖因子の製造方法
US11820988B2 (en) * 2019-02-28 2023-11-21 Purdue Research Foundation Nanoparticles and biotemplates with tunable length and methods of manufacturing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316931A (en) 1988-02-26 1994-05-31 Biosource Genetics Corp. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
US5977438A (en) 1988-02-26 1999-11-02 Biosource Technologies, Inc. Production of peptides in plants as viral coat protein fusions
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5412087A (en) 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
IL108241A (en) 1992-12-30 2000-08-13 Biosource Genetics Corp Plant expression system comprising a defective tobamovirus replicon integrated into the plant chromosome and a helper virus
US5955647A (en) * 1994-02-03 1999-09-21 The Scripps Research Institute Method for using tobacco mosaic virus to overproduce peptides and proteins
US5695937A (en) 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5816653A (en) 1997-03-17 1998-10-06 Schukra Of North America Ltd. Apparatus and method for adjusting the position of a supporting element in a seat
WO2000066743A2 (en) 1999-05-04 2000-11-09 Large Scale Biology Corporation Viral expression vectors

Also Published As

Publication number Publication date
AU781020B2 (en) 2005-04-28
CA2373026C (en) 2011-05-03
WO2000066743A3 (en) 2001-04-26
KR20020000802A (ko) 2002-01-05
WO2000066743A2 (en) 2000-11-09
US20050175590A1 (en) 2005-08-11
WO2000066743A9 (en) 2002-03-14
US7132588B2 (en) 2006-11-07
BR0010222A (pt) 2002-03-19
JP4750285B2 (ja) 2011-08-17
US6656726B1 (en) 2003-12-02
IL146191A0 (en) 2002-07-25
ES2332982T3 (es) 2010-02-16
AU4824700A (en) 2000-11-17
DE60042922D1 (de) 2009-10-22
CA2373026A1 (en) 2000-11-09
JP2002542828A (ja) 2002-12-17
EP1181372A2 (de) 2002-02-27
EP1181372B1 (de) 2009-09-09
ZA200108528B (en) 2002-10-17

Similar Documents

Publication Publication Date Title
ES2664505T3 (es) Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas
FR19C1020I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
HUP0301659A2 (hu) Kukorica cellulóz-szintetázok és alkalmazásuk
NO20030621L (no) Anti-dual integrinantistoffer, sammensetninger, fremgangsmater og anvendelser
ATE270342T1 (de) Endosomolytisch wirksame partikel
DE60144145D1 (de) Subtilisin-variante
DK0561890T3 (da) DNA ekspressionssystemer baseret på alphavira
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
ATE529441T1 (de) Expression von proteinen in e.coli
DE60128149D1 (en) Putrescin-n-methyltransferasepromotor
DE60041243D1 (de) Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins
WO2002079239A3 (en) Chimeric filovirus glycoprotein
ATE442441T1 (de) Virale expressionsvektoren für pflanzen
DE60034966D1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
FI961202A (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
EP1412374A4 (de) Neue pgc-1-isoformen und deren verwendungen
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
ATE323767T1 (de) Impfstoff für die infektiöse peritonitis der katzen
WO2002070691A3 (en) Abcg4 transporter and uses thereof
ATE406446T1 (de) Vermehrungsproteine von pflanzen
DK1328621T3 (da) 13245, en ny human proteinkinase af den myotoniske dystrofitype og anvendelser deraf
WO2005007827A3 (en) Avian adeno-associated virus vector
WO2001081584A3 (en) 27960, a novel ubiquitin conjugating enzyme family member and uses therefor
DE60330140D1 (de) Gen-silencing-vektor und diesen verwendendes gen-silencing-verfahren
DE60136832D1 (de) Atcr-1, eine humane acyltransferase und verwendungen davon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties